WADA PROHIBITED Section S2 (2025 Prohibited List) Ipamorelin is explicitly named on the World Anti-Doping Agency (WADA) Prohibited List 2025 under Section S2 Peptide Hormones, Growth Factors, Related Substances and Mimetics as a prohibited growth-hormone secretagogue
The pharmacokinetic interaction is absent, the pharmacodynamic interaction is dose-dependent, and 300 mg/day falls below the threshold where thyroid or significant glucose effects have been consistently documented
Thus, oxidative damage in depression and anxiety disorders can affect the amygdala and hippocampus (Salim, 2017), among other brain structures, reduce neurogenesis (van Velzen et al., 2017), and contribute to cognitive dysfunction (Lindqvist et al., 2017), such as proinflammatory cytokines (Slavich et al., 2020)
It found that the risk of alopecia for people taking GLP-1s was 37% higher than for people taking SGLT-2 inhibitors, and 68% higher than for those taking DPP-4 inhibitors
